• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一起可预防的、改变人生的氟喹诺酮类药物相关肌腱炎案例。

A preventable, life-altering case of fluoroquinolone-associated tendonitis.

机构信息

At the time this article was written, Anne Wildermuth was an assistant professor and Megan Holmes was a student in the PA program at the University of Nebraska Medical Center in Omaha. Ms. Wildermuth now is the associate program director and an assistant professor in the PA program at George Washington University in Washington, D.C. Ms. Holmes now practices at Bryan Heart Vascular Surgery in Lincoln, Neb. The authors have disclosed no potential conflicts of interest, financial or otherwise.

出版信息

JAAPA. 2022 Nov 1;35(11):33-36. doi: 10.1097/01.JAA.0000873776.37967.9b.

DOI:10.1097/01.JAA.0000873776.37967.9b
PMID:36282576
Abstract

Fluoroquinolones, such as ciprofloxacin and levofloxacin, are broad-spectrum antibacterial agents that have historically been widely used for urinary tract infections, pneumonia, and intra-abdominal infections but are associated with several serious adverse reactions, including tendinopathy and tendon rupture, peripheral neuropathy, and aortic aneurysm. These drugs should not be used for uncomplicated infections unless no other antimicrobial treatment is feasible. This article describes a patient who experienced life-altering disability from a fluoroquinolone, reviews the adverse reactions of this drug class, and discusses recommended treatment for acute uncomplicated cystitis and asymptomatic bacteriuria.

摘要

氟喹诺酮类药物,如环丙沙星和左氧氟沙星,是一种广谱抗菌药物,历史上被广泛用于治疗尿路感染、肺炎和腹腔内感染,但与多种严重不良反应有关,包括肌腱病和肌腱断裂、周围神经病和主动脉瘤。除非没有其他抗菌治疗方法可行,否则这些药物不应用于单纯感染。本文描述了一位因氟喹诺酮类药物而致残的患者,回顾了该类药物的不良反应,并讨论了急性单纯性膀胱炎和无症状菌尿症的推荐治疗方法。

相似文献

1
A preventable, life-altering case of fluoroquinolone-associated tendonitis.一起可预防的、改变人生的氟喹诺酮类药物相关肌腱炎案例。
JAAPA. 2022 Nov 1;35(11):33-36. doi: 10.1097/01.JAA.0000873776.37967.9b.
2
Fluoroquinolone-Associated Tendinopathy: Does Levofloxacin Pose the Greatest Risk?氟喹诺酮类药物相关性肌腱病:左氧氟沙星的风险最大吗?
Pharmacotherapy. 2016 Jun;36(6):679-93. doi: 10.1002/phar.1761. Epub 2016 Jun 11.
3
[Fluoroquinolone-induced tendon diseases].[氟喹诺酮类药物引起的肌腱疾病]
An Med Interna. 2007 May;24(5):227-30. doi: 10.4321/s0212-71992007000500005.
4
Fluoroquinolone-associated tendinopathy.氟喹诺酮相关性肌腱病
Chang Gung Med J. 2011 Sep-Oct;34(5):461-7.
5
Fluoroquinolone-mediated Achilles rupture: a case report and review of the literature.氟喹诺酮类药物介导的跟腱断裂:一例病例报告及文献综述
J Foot Ankle Surg. 2015 May-Jun;54(3):494-6. doi: 10.1053/j.jfas.2014.09.037. Epub 2014 Nov 15.
6
Fluoroquinolone-Associated Tendinopathy of the Hand and Wrist: A Systematic Review and Case Report.氟喹诺酮类药物相关的手部和腕部肌腱病:一项系统评价和病例报告
Hand (N Y). 2017 Sep;12(5):NP121-NP126. doi: 10.1177/1558944717701237. Epub 2017 Apr 3.
7
Association between oral fluoroquinolone use and lateral canthal tendon rupture: case report.口服氟喹诺酮类药物使用与外眦肌腱断裂之间的关联:病例报告。
Orbit. 2018 Oct;37(5):358-360. doi: 10.1080/01676830.2017.1423357. Epub 2018 Jan 5.
8
Fluoroquinolones and tendinopathy: a guide for athletes and sports clinicians and a systematic review of the literature.氟喹诺酮类药物与肌腱病:运动员及运动医学临床医生指南及文献系统综述
J Athl Train. 2014 May-Jun;49(3):422-7. doi: 10.4085/1062-6050-49.2.09. Epub 2014 Apr 24.
9
A risk-benefit assessment of levofloxacin in respiratory, skin and skin structure, and urinary tract infections.左氧氟沙星用于呼吸道、皮肤及皮肤结构和尿路感染的风险效益评估。
Drug Saf. 2001;24(3):199-222. doi: 10.2165/00002018-200124030-00004.
10
Fluoroquinolone-induced Achilles tendinitis.氟喹诺酮类药物引起的跟腱炎。
Hong Kong Med J. 2014 Dec;20(6):545-7. doi: 10.12809/hkmj134105.

引用本文的文献

1
Fluoroquinolones for Dermatologists: A Practical Guide to Clinical Use and Risk Management.皮肤科医生使用氟喹诺酮类药物:临床应用与风险管理实用指南
Pharmaceuticals (Basel). 2025 May 26;18(6):800. doi: 10.3390/ph18060800.